Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-up.
about
Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-up.
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Treatment of neuromyelitis opt ...... itoring. A six-year follow-up.
@ast
Treatment of neuromyelitis opt ...... itoring. A six-year follow-up.
@en
Treatment of neuromyelitis opt ...... itoring. A six-year follow-up.
@nl
type
label
Treatment of neuromyelitis opt ...... itoring. A six-year follow-up.
@ast
Treatment of neuromyelitis opt ...... itoring. A six-year follow-up.
@en
Treatment of neuromyelitis opt ...... itoring. A six-year follow-up.
@nl
prefLabel
Treatment of neuromyelitis opt ...... itoring. A six-year follow-up.
@ast
Treatment of neuromyelitis opt ...... itoring. A six-year follow-up.
@en
Treatment of neuromyelitis opt ...... itoring. A six-year follow-up.
@nl
P2093
P1476
Treatment of neuromyelitis opt ...... nitoring. A six-year follow-up
@en
P2093
C Kilidireas
D S Evangelopoulos
I Evdokimidis
M Anagnostouli
M E Evangelopoulos
P356
10.1016/J.JNS.2016.11.016
P577
2016-11-10T00:00:00Z